1803 related articles for article (PubMed ID: 7699327)
1. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of IL-10 protein synthesis induces major histocompatibility complex class II gene expression in class II-deficient patients.
Hauber I; Wolf HM; Samstag A; Pein B; Kreil TR; Gulle H; Fischer MB; Eibl MM
Cell Immunol; 1997 Sep; 180(2):95-103. PubMed ID: 9341739
[TBL] [Abstract][Full Text] [Related]
3. Uncoordinated HLA-D gene expression in a RFXANK-defective patient with MHC class II deficiency.
Lennon-Duménil AM; Barbouche MR; Vedrenne J; Prod'Homme T; Béjaoui M; Ghariani S; Charron D; Fellous M; Dellagi K; Alcaïde-Loridan C
J Immunol; 2001 May; 166(9):5681-7. PubMed ID: 11313409
[TBL] [Abstract][Full Text] [Related]
4. Type III bare lymphocyte syndrome: lack of HLA class II gene expression and reduction in HLA class I gene expression.
Sabatier C; Gimenez C; Calin-Laurens V; Rabourdin-Combe C; Touraine JL
C R Acad Sci III; 1996 Sep; 319(9):789-98. PubMed ID: 8952882
[TBL] [Abstract][Full Text] [Related]
5. Residual expression of functional MHC class II molecules in twin brothers with MHC class II deficiency is cell type specific.
Wolf HM; Thon V; Gulle H; Lechleitner S; Eibl MM; Petzelbauer P
Br J Haematol; 2001 Nov; 115(2):460-71. PubMed ID: 11703350
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
7. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
Muczynski KA; Anderson SK; Pious D
J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
[TBL] [Abstract][Full Text] [Related]
8. Cooperativity between the J and S elements of class II major histocompatibility complex genes as enhancers in normal and class II-negative patient and mutant B cell lines.
Sugawara M; Scholl T; Mahanta SK; Ponath PD; Strominger JL
J Exp Med; 1995 Jul; 182(1):175-84. PubMed ID: 7790817
[TBL] [Abstract][Full Text] [Related]
9. Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome.
Kovats S; Nepom GT; Coleman M; Nepom B; Kwok WW; Blum JS
J Clin Invest; 1995 Jul; 96(1):217-23. PubMed ID: 7615790
[TBL] [Abstract][Full Text] [Related]
10. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
Diedrichs M; Schendel DJ
J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
[TBL] [Abstract][Full Text] [Related]
11. Combined immunodeficiency with defective expression in major histocompatibility complex class II genes.
Griscelli C
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 2):S106-10. PubMed ID: 1934608
[TBL] [Abstract][Full Text] [Related]
12. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
13. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
de Waal Malefyt R; Haanen J; Spits H; Roncarolo MG; te Velde A; Figdor C; Johnson K; Kastelein R; Yssel H; de Vries JE
J Exp Med; 1991 Oct; 174(4):915-24. PubMed ID: 1655948
[TBL] [Abstract][Full Text] [Related]
15. Genetic evidence for a new type of major histocompatibility complex class II combined immunodeficiency characterized by a dyscoordinate regulation of HLA-D alpha and beta chains.
Douhan J; Hauber I; Eibl MM; Glimcher LH
J Exp Med; 1996 Mar; 183(3):1063-9. PubMed ID: 8642248
[TBL] [Abstract][Full Text] [Related]
16. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
[TBL] [Abstract][Full Text] [Related]
17. Presentation of soluble antigen to human T cells by products of multiple HLA-linked loci: analysis of antigen presentation by a panel of cloned, autologous, HLA-mutant Epstein-Barr virus-transformed lymphoblastoid cell lines.
Chen BP; DeMars R; Sondel PM
Hum Immunol; 1987 Jan; 18(1):75-91. PubMed ID: 3542914
[TBL] [Abstract][Full Text] [Related]
18. Allorecognition and T cell repertoire selection in severe combined immunodeficiency lacking HLA class II antigens.
Knobloch C; Ballas M; Wölpl A; Friedrich W
Transplantation; 1992 Jun; 53(6):1295-301. PubMed ID: 1534939
[TBL] [Abstract][Full Text] [Related]
19. Combined immunodeficiency with defective expression in MHC class II genes.
Griscelli C; Lisowska-Grospierre B; Mach B
Immunodefic Rev; 1989; 1(2):135-53. PubMed ID: 2517209
[TBL] [Abstract][Full Text] [Related]
20. Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency.
de Préval C; Hadam MR; Mach B
N Engl J Med; 1988 May; 318(20):1295-300. PubMed ID: 3129659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
